Author:
Gibbons Alison,Farmer Cristan,Shaw Jacob S,Chung Joyce Y
Abstract
AbstractObjectivesThe DSM-5 Level 1 Cross-Cutting Symptom Measure (DSM-XC) is a transdiagnostic mental health symptom measure that has shown promise in informing clinical diagnostic evaluations and as a screening tool for research. However, few studies have assessed the latent dimensionality of the DSM-XC. We examined the factor structure of the DSM-XC in a large convenience sample of participants with varying degrees of psychological health.MethodsParticipants (n=3533) enrolled in a protocol conducted at the National Institute of Mental Health (NCT04339790). We used a factor analytic framework to evaluate an existing two-factor solution (Lace & Merz, 2020) and two additional candidate solutions.ResultsThe Lace and Merz solution had acceptable fit. Exploratory factor analysis yielded two candidate solutions: a six-factor (characterized as mood, worry, activation, somatic, thoughts, and substance use) and a bifactor (general factor of non-specific psychopathology, residual factors characterized as internalizing and thought disorder), which both had good fit and full measurement invariance across age, sex, and enrollment date.ConclusionsOur findings confirm that the DSM-XC may be conceptualized as a multidimensional instrument and provide a scoring solution for researchers who wish to measure distinct constructs. Future research on the psychometric profile of the DSM-XC is needed, focused on the validity of these candidate solutions and their performance across research populations and settings.
Publisher
Cold Spring Harbor Laboratory
Reference29 articles.
1. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health | SAMHSA Publications and Digital Products [Internet]. 2020 [cited 2021 Feb 24]. Available from: https://store.samhsa.gov/product/key-substance-use-and-mental-health-indicators-in-the-united-states-results-from-the-2019-national-survey-on-Drug-Use-and-Health/PEP20-07-01-001
2. The PHQ-9
3. Dimensional and Cross-Cutting Assessment in the DSM-5;J Couns Dev,2012
4. DSM-5 Field Trials in the United States and Canada, Part III: Development and Reliability Testing of a Cross-Cutting Symptom Assessment for DSM-5
5. DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care?;World Psychiatry,2014
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献